Ensorex 50mg Tablet contains Amantadine 50mg, an antiviral and antiparkinsonian agent primarily used in the management of Parkinson’s disease and drug-induced extrapyramidal symptoms. Amantadine acts by increasing dopamine release and blocking its reuptake in the central nervous system, thereby improving motor function and reducing rigidity and tremors associated with Parkinsonism. Additionally, it exhibits antiviral properties against influenza A virus by inhibiting viral replication. Ensorex is indicated for the symptomatic treatment of Parkinson’s disease, post-encephalitic Parkinsonism, and to alleviate extrapyramidal side effects caused by neuroleptic medications. The recommended dosage should be individualized based on patient response and tolerance, with careful titration to minimize adverse effects. Common side effects may include dizziness, insomnia, dry mouth, nausea, and in some cases, peripheral edema or livedo reticularis. Caution is advised in patients with renal impairment, as dosage adjustment may be necessary. Ensorex should be used under medical supervision, with regular monitoring for therapeutic efficacy and potential adverse reactions. It is contraindicated in patients with hypersensitivity to Amantadine or related compounds. Ensorex 50mg Tablet offers a valuable therapeutic option in the management of Parkinsonian syndromes and certain viral infections, contributing to improved patient quality of life.